A new Drug Enforcement Agency rule set to take effect next month could spur health IT adoption among providers by eliminating the requirement that they still use a paper-based system for controlled substances. Under the new rule, they will be allowed to use e-prescriptions for controlled substances. "Physicians will adopt e-prescribing much more rapidly when there is a singular work flow -- whether it's Lipitor or Valium," said Dr. John Halamka, Beth Israel Deaconess Medical Center CIO and Health IT Standards Committee co-chairman.

Related Summaries